NG-345

N/A

Report date: 2025/01/26 16:04:46

Base Information

Drug NameNG-345
Drug Alias Nameoncolytic adenovirus therapy expressing cytokines + chemokines (PsiOxus)NG-345
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionChemokines agonistsCytokine receptors agonists
TargetsChemokinesCytokine receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkamis Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAkamis Bio Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A